Find Academic Supervisors

Herman BarkemaView profile

Professor

• Epidemiology of Infectious Diseases
• Antimicrobial Resistance
• Veterinary Epidemiology
• +3 more

Herman Barkema is a Professor in Epidemiology of Infectious Diseases at the Faculty of Veterinary Medicine, University of Calgary, with a joint appointment in the Department of Community Health Sciences, Cumming School of Medicine. His research focuses on preventing infectious diseases in cattle herds (e.g., mastitis, Johne’s disease) and antimicrobial resistance, integrating animal and public health perspectives under the One Health framework. He founded the Department of Production Animal Health and leads the AMR – One Health Consortium and CAN-AMR-Net. DVM, Veterinary Medicine, Utrecht University (1988) PhD, Veterinary Science, Utrecht University (1998) His work spans clinical veterinary epidemiology, antimicrobial resistance mechanisms, and zoonotic disease control. He has over 425 publications and collaborates globally, including as a Foreign Expert at China Agricultural University. Recent research trends highlight his focus on multi-omics approaches, ceRNA networks, and antimicrobial stewardship in dairy systems, with significant contributions to Johne’s disease diagnostics and mastitis prevention. Roger Morris ISVEE Award (2024) Plowright Prize (2022) Killam Annual Professorship (2019) Multiple Journal of Dairy Science Most Cited Awards (2011–2024) Fellow, Canadian Academy of Health Sciences (2014) Dr. Barkema supervises graduate students and postdoctoral fellows, emphasizing interdisciplinary mentorship. He co-developed the Veterinary DialogueTrainer for clinical communication training and participates in public engagement initiatives like Breakfast on the Farm. He leads the AMR – One Health Consortium and CAN-AMR-Net, integrating stakeholders across Canada and internationally. His affiliations include the Snyder Institute for Chronic Diseases and strategic initiatives on Infectious Diseases and One Health (2015–2025).

Adam IrwinView profile

Associate Professor

• Infectious Diseases
• Pediatric Medicine
• Antimicrobial Resistance
• +3 more

Associate Professor Adam Irwin is an NHMRC Emerging Leadership Fellow and Associate Professor in Infectious Diseases at the University of Queensland (UQ) and Queensland Children’s Hospital. He holds positions within the UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. His work focuses on early sepsis recognition, antimicrobial stewardship, and pediatric infectious diseases. Dr. Irwin completed his medical degree at the University of Birmingham and his PhD in 2016 from the University of Liverpool’s Institute of Infection and Global Health. He has led initiatives like the Queensland Paediatric Sepsis Program, recognized with a Global Sepsis Alliance Award and Queensland Health Excellence Awards. His research spans sepsis pathway implementation, antimicrobial resistance trends, and rapid diagnostic tools. Notable grants include NHMRC funding for studies on multi-drug resistant infections and Children’s Hospital Foundation support for genomics and antimicrobial stewardship projects. He supervises PhD candidates in areas like bloodstream infections and molecular diagnostics. Dr. Irwin collaborates across institutions, contributing to projects such as the RAPIDS Study Group and the PAEDS surveillance network. Awards include the NHMRC Emerging Leadership Fellowship and recognition for sepsis program excellence. His work emphasizes translating research into clinical practice, improving outcomes for critically ill children through evidence-based protocols and innovative diagnostics.

Hyun KooView profile

Professor

• Biofilms
• Oral Infectious Diseases
• Nanotechnology
• +3 more

Hyun (Michel) Koo is a Professor at the University of Pennsylvania School of Dental Medicine , with affiliations in the Department of Orthodontics , Division of Community Oral Health , and Division of Pediatric Dentistry . As Co-Founder and Co-Director of the Center for Innovation & Precision Dentistry (CiPD) , he leads interdisciplinary efforts merging bioengineering, nanotechnology, and oral health research. Education : DDS and PhD Research Focus : Biofilms, bacterial-fungal interactions, and nanotechnology for oral disease prevention Leadership : Co-Director of CiPD; key roles in training programs like NIDCR-sponsored R90 and T90/R90 Dr. Koo’s research explores biofilm mechanisms in oral infectious diseases, particularly childhood caries, through engineering methods and microrobotics . His team developed micron-scale robots for automated biofilm eradication and FDA-approved nanoparticles for caries prevention. Collaborations with Penn Engineering, including Dr. Daeyeon Lee and Dr. Kacy Cullen, emphasize translational approaches. The 15 most recent publications highlight his work in nanorobotics , interkingdom biofilms , and precision diagnostics . Articles span 2025–2024 and address topics like adaptive micromotors , biofilm matrix degradation , and single-cell microbial interactions . These emphasize his focus on targeted therapies and biofilm microenvironment engineering . Key Awards : Elected Fellow, American Association for the Advancement of Science (AAAS) IADR Distinguished Scientist Award for innovative dental research Dr. Koo trains next-generation researchers through the CiPD NIDCR T90/R90 Postdoctoral Training Program , mentoring fellows like Smruti Nair (ACE2 Chewing Gum development) and Zhi Ren (K99 awardee). His work intersects with Penn Health-Tech, CT3N , and Penn Institute for Biomedical Informatics , fostering transdisciplinary innovation.

Finlay MaguireView profile

Assistant Professor

• Genomic Epidemiology
• Health Data Science
• Bioinformatics
• +7 more

Finlay Maguire is an Assistant Professor jointly appointed in the Faculty of Computer Science and the Department of Community Health & Epidemiology at Dalhousie University. He leads the Maguire Lab, which develops data-driven methods to address health and social crises through genomic epidemiology and interdisciplinary health data science. He is also affiliated with the Shared Hospital Laboratory, Sunnybrook Research Institute, and multiple national and international public health consortia including PHA4GE, CanCOGeN, and IRIDA. PhD: University College London / Natural History Museum (2016) MA: University of Oxford (2011) Donald Hill Family Fellowship, Dalhousie University (2021) Dr. Maguire's research focuses on two main areas: genomic epidemiology of infectious diseases and interdisciplinary health data science collaborations . His work in genomic epidemiology includes developing bioinformatics and machine learning tools to study antimicrobial resistance (AMR) and SARS-CoV-2 dynamics, often in collaboration with public health agencies. His broader health data science work addresses issues such as online radicalization, healthcare access for refugees, and autism-related language use, combining computational methods with social science. His recent publications (2023–2025) reflect a strong trend in pathogen genomics , AMR , zoonotic spillover , and computational social science . He has published on novel coronaviruses in bats, SARS-CoV-2 animal models, invasive Group A Streptococcus, and sociological analyses of incel communities. Much of this work involves tool development (e.g., ArgNorm, Pathoplexus) and data standardization (e.g., PHA4GE metadata standards). Finalist, 2024 Discovery Awards (Emerging Professional) 2023 President’s Research Excellence Award for an Emerging Investigator, Dalhousie Finalist, 2023 Discovery Awards (Emerging Professional) Funding from CIHR, NSERC, Genome Canada, SSHRC, BMGF Dr. Maguire actively mentors graduate students and postdocs, including PhD candidates in Computer Science and MSc students in Community Health & Epidemiology. He has secured major training grants such as the CIHR Health Research Training Platform and the Canadian One Health Training Program for Emerging Zoonoses. He also contributes to capacity-building initiatives like MicroResearch in Ghana and Kenya. The Maguire Lab is embedded in a rich network of collaborations, including the CARD database, Public Health Agency of Canada, Canadian Food Inspection Agency, and Sunnybrook Health Sciences Centre. The lab emphasizes open science, reproducible research, and interdisciplinary training, as seen in the development of open-source tools and participation in international consortia.

• Obstetrics
• Maternal and Neonatal Outcomes
• Epidemiology
• +12 more

Jessica Illuzzi is the Deputy Dean for Education and Harold W. Jockers Professor of Medical Education at the Yale School of Medicine, where she is also a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. She plays a pivotal role in medical education leadership, curriculum development, and accreditation efforts, while maintaining an active research program in maternal and neonatal health. Harvard University, AB in Biochemical Sciences (1994) Harvard Medical School, MD (1998) Yale School of Graduate Studies, MS in Epidemiology (2006) Residency in Obstetrics and Gynecology, Yale-New Haven Hospital (2002) Her research focuses on the impact of obstetric interventions on maternal and neonatal outcomes, especially among low-risk women. Key areas include cesarean section, vaginal birth after cesarean (VBAC), group B streptococcus prophylaxis, and innovative maternity care models. She has led studies on labor management, health disparities, and quality improvement in obstetric care. Recent publications highlight trends in racial and ethnic disparities in maternal outcomes, validation of VBAC prediction tools, neonatal resuscitation guidelines, and integrated maternal-child care models in Haiti. Her work spans clinical epidemiology, health services research, and digital health interventions in obstetrics. Hellman Award (2017) Leah Lowenstein Award (2010) Roy M. Pitkin Award (2010) Bohmfalk Award (2007) Association of Professors of Gynecology and Obstetrics Teaching Award (2006) Dr. Illuzzi has been a strong advocate for medical education reform and student mentorship. She previously served as clerkship director and curriculum director, and has played key roles in Yale’s curriculum redesign and LCME reaccreditation. She has also led quality improvement initiatives in labor care and contributed to national guidelines on neonatal resuscitation. Her collaborative research network includes frequent co-authors such as Xiao Xu and Katherine Harper Campbell.

• Immunology
• Virology
• Inflammation
• +5 more

Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.

• Clinical Microbiology
• Infectious Diseases
• Rapid Diagnostics
• +3 more

Susan Butler-Wu, PhD, D(ABMM), SM (ASCP) serves as the Director of Medical Microbiology at LAC+USC Medical Center and holds the position of Clinical Associate Professor of Clinical Pathology at the Keck School of Medicine of the University of Southern California. She received her PhD in Molecular Microbiology from Tufts University and completed postdoctoral fellowships in Tuberculosis Pathogenesis at New York University and Medical and Public Health Microbiology at the University of Washington. Prior to her current role, she was the Associate Director of Clinical Microbiology at the University of Washington Medical Center. Research Focus: Rapid diagnostics for infectious diseases, antimicrobial resistance detection, and diagnostic stewardship. Professional Roles: Member of the editorial board of the Journal of Clinical Microbiology; serves on working groups for the Clinical Laboratory Standards Institute (CLSI) and the American Society for Microbiology (ASM). Key Contributions: Extensive publications on MALDI-TOF mass spectrometry, SARS-CoV-2 diagnostics, and antimicrobial resistance trends.

David N. LangelaanView profile

Associate Professor

• Structural Biology
• Protein-Protein Interactions
• Cellular Signaling
• +5 more

David N. Langelaan is an Associate Professor in the Department of Biochemistry and Molecular Biology at Dalhousie University, within the Faculty of Medicine. He holds a PhD from Dalhousie University and has been a department member since 2016. His research focuses on structural biology, protein-protein interactions, cellular signaling, and protein engineering. Key projects include hydrophobin characterization and engineering, studying MITF's role in melanoma and development, and analyzing rhodoquinone biosynthesis in anaerobic environments. Education: PhD, Dalhousie University. Research Themes: Structural biology, protein assemblies, microbial biochemistry, cancer biology. His lab employs techniques like NMR spectroscopy, X-ray crystallography, and isothermal titration calorimetry. Current lab members include graduate students (Raymond He, Trilok Neupane) and honours students (Alex Bouchard, Janani Venkat). Funding is provided by agencies such as NSERC, CFI, and the Dalhousie Medical Research Foundation. Publications highlight contributions to antimicrobial mechanisms, transcription factor signaling, and hydrophobin self-assembly. Recent work examines MITF coactivator interactions and rhodoquinone biosynthesis pathways in bacteria.

Frank OechslinView profile

Assistant Professor

• Bacteriophage
• Endolysins
• Phage Therapy
• +4 more

Dr. Frank Oechslin is an Assistant Professor at the Department of Biochemistry, Microbiology and Immunology within the Faculty of Medicine at the University of Ottawa. He leads a research group focused on bacteriophages (phages) and their lytic enzymes (endolysins), investigating their potential to combat antibiotic-resistant bacteria. His lab is located in Roger Guindon Hall, Ottawa, Canada. PhD in Bacteriology, University of Lausanne, Switzerland Postdoctoral training at Université Laval, Québec (2018), supported by Swiss National Science Foundation Research interests span phage therapy, antimicrobial resistance, synthetic biology, and experimental evolution. His work employs CRISPR-Cas genome editing and advanced synthetic biology to explore phage-endolysin interactions, bacterial cell wall dynamics, and evolutionary adaptation mechanisms. Publications highlight thermostable endolysins, host specificity, and phage-antibiotic synergy. Scientific awards include a Swiss National Science Foundation Fellowship. His lab collaborates with Prof. Sylvain Moineau's team and focuses on engineering phages for clinical applications, particularly in treating infections caused by multi-drug-resistant pathogens like Pseudomonas aeruginosa and Streptococcus agalactiae .

Joe F. LutkenhausView profile

Professor

• Bacterial Cytokinesis
• Cell Division
• Molecular Biology
• +3 more

Dr. Joe F. Lutkenhaus is a University Distinguished Professor and Chair of the Department of Microbiology, Molecular Genetics and Immunology at the University of Kansas School of Medicine. A member of the American Academy of Microbiology (2002) and the National Academy of Sciences (2014), he has received prestigious accolades including the Louisa Gross Horwitz Prize (2012) and an NIH Merit Award. BSc, Chemistry, Iowa State University PhD, Biochemistry, UCLA Postdoctoral Fellowship, Molecular Biology, University of Edinburgh Postdoctoral Fellowship, Microbiology, University of Connecticut His research focuses on bacterial cytokinesis, particularly the molecular mechanisms of the Z ring and divisome complex in Escherichia coli . Key areas include spatial/temporal regulation of septation, protein interactions (FtsZ, FtsA, FtsEX), and the evolution of cell division machinery across prokaryotes. Recent work explores photosynthesis-related proteins in haloarchaeal division and the self-enhancing nature of divisomes in Caulobacter crescentus . Scientific contributions span over 40 years, with 15 most recent publications highlighting regulatory mechanisms of FtsZ polymers, ATP-dependent divisome assembly, and novel protein interactions. Articles demonstrate expertise in bacterial cell cycle regulation, peptidoglycan synthesis, and cytoskeletal dynamics. Recipient, Louisa Gross Horwitz Prize (2012) NIH Merit Award Member, National Academy of Sciences (2014–Present) Member, American Academy of Microbiology (2002–Present) Dr. Lutkenhaus's lab has contributed to understanding Z ring kinetics, FtsEX-FtsA interactions, and Min system oscillation. His work bridges fundamental bacterial biology with implications for antibiotic development, supported by continuous NIH funding and collaborations across structural biology and genetics.

Emmanuel HoView profile

Professor

• Nanomedicine
• Vaccine Delivery
• Drug Delivery Systems
• +3 more

Emmanuel Ho is a Professor at the University of Waterloo and serves as the Associate Director of Graduate Studies & Research. His research focuses on nanomedicine and vaccine delivery, with expertise in drug delivery systems, polymer chemistry, and biomaterials. He leads the Ho Research Group, dedicated to developing innovative biomedical technologies for healthcare challenges. His work integrates materials science, pharmacology, and engineering to address issues in infectious diseases, ocular health, and drug delivery mechanisms. Key research areas include the design of smart polymers for targeted drug delivery, development of biosensors for rapid pathogen detection, and the application of nanotechnology in combating antimicrobial resistance. His projects often involve interdisciplinary collaborations, such as combining machine learning with nanoparticle formulation design to optimize therapeutic efficacy. Recent advancements from his lab include microwave biosensors for E. coli detection, bacteria-responsive drug release platforms, and pH-sensitive nanomicrobicides for HIV prevention. These innovations highlight his commitment to translating cutting-edge science into practical medical solutions. The Ho Research Group’s work has been widely published in top-tier journals, reflecting its impact on both academic and clinical fields.

Lars BjörckView profile

Professor

• Protein Biochemistry
• Immunology and Microbiology
• Genetics and Molecular Biology
• +3 more

Lars Björck is a Professor and Associate Professor in Infection Medicine at Lund University’s Faculty of Medicine, affiliated with the BMC (Clinical Sciences Lund) campus. He serves as a Project Manager for Molecular Pathogenesis and a researcher in the epIgG and Infect@LU research groups. His work focuses on bacterial pathogenesis, immune modulation, and infectious disease mechanisms. Key research areas include Streptococcus pyogenes proteinases (e.g., IdeS), antibody interactions, and bacterial evasion of host immune responses. Research interests span bacterial protein function, antibody inactivation mechanisms, and vaccine development. His projects include studying immune modulating proteins (SIC and IdeS) and developing monoclonal antibodies against streptococcal pathogens. He has contributed to over 135 research outputs, with recent work emphasizing Streptococcal proteins’ roles in immune evasion and inflammatory responses. Lars Björck has led major projects such as the Hygieia initiative, a collaborative effort to develop strategies for infectious disease prevention and treatment. His research bridges molecular biology, immunology, and clinical applications, with a focus on translating findings into therapeutic solutions for infectious diseases.

• Obstetrics
• Gynaecology
• Maternal Health
• +5 more

Clinical Associate Professor Therese McGee is affiliated with the Westmead Clinical School, part of the Sydney Medical School at the University of Sydney. Her work focuses on maternal and neonatal health, particularly in obstetrics and gynaecology, with a strong emphasis on clinical research and guideline implementation. She investigates diverse topics such as perinatal outcomes, pandemic impacts on healthcare, and optimizing healthcare delivery models. Her research often addresses challenges in multiethnic populations and evaluates interventions to improve patient care and reduce healthcare costs. Her research interests include perinatal care, gestational diabetes, hypertensive disorders in pregnancy, and the validation of hospital data to ensure accurate reporting of maternal medical conditions. She also explores fetal surveillance techniques, neonatal jaundice management, and the efficacy of midwifery-led care models. Her work frequently employs mixed-methods and cohort study designs, reflecting a commitment to evidence-based practice. Therese has contributed to studies on uterine rupture, anaemia in pregnancy, and the use of rapid diagnostic tests for preventing neonatal infections. Her articles highlight a focus on healthcare quality, patient-centered care, and improving clinical guidelines through rigorous analysis. The scope of her research spans both clinical and public health dimensions, addressing issues such as antibiotic exposure reduction and maternal morbidity in Australian contexts. Grants: Efficacy and safety of vaccination in at-risk pregnant women and impact on infant immune responses (2017) Are we there yet? Optimising timing of planned birth to improve newborn outcomes and reduce health service costs (2017) Therese is involved in collaborative projects through Sydney Health Partners, focusing on applied research with real-world healthcare implications. Her studies often involve interdisciplinary teams, reflecting her role in bridging clinical practice and academic research. While no formal student advisees are listed, her publications suggest active participation in mentoring research cohorts.

• Veterinary Epidemiology
• Antimicrobial Resistance
• One Health
• +3 more

Professor Ruth Zadoks is a faculty member at the Sydney School of Veterinary Science, University of Sydney. She holds academic positions in the Sydney Institute of Agriculture and Sydney Southeast Asia Centre, and is involved with the Sydney Infectious Diseases Institute. Her research focuses on antimicrobial resistance, zoonotic diseases, bovine health, and One Health principles. Notable projects include investigations into Japanese encephalitis transmission dynamics, antibiotic use in East African livestock, and molecular epidemiology of Group B Streptococcus. Recent grants include studies on microbial spillover in aquaculture and precision feeding in broiler chickens. Her work integrates veterinary and public health perspectives, addressing issues like anthrax impacts in rural Africa, tilapia-borne zoonoses, and diagnostic innovations for bovine mastitis. Over 118 peer-reviewed publications highlight her contributions to aquatic pathogen genomics, food safety, and livestock disease ecology. Recent grants (2024): - Revealing microbial spillover drivers in aquaculture (SSEAC Incubator) - Sustainable Precision Feeding in Broiler Chickens (AgriFutures) - ASEAN Antimicrobial Resistance Network (DFAT-funded) Labs/Teams: Affiliated with Sydney Infectious Diseases Institute and collaborates across interdisciplinary One Health networks.

Hasan SamraView profile

Assistant Professor

• Infectious Diseases
• Clinical Pathology
• Medical Microbiology
• +5 more

Hasan Samra is an Assistant Professor at Augusta University’s Medical College of Georgia, specializing in the Department of Pathology with a focus on Clinical Pathology. His academic and clinical work bridges diagnostic pathology with infectious diseases, emphasizing rare and complex infections in immunocompromised populations. Education: MD from Syrian Private University (2014) Certifications: Georgia Professional Licensing (BRD, 2021) Dr. Samra’s research explores emerging infectious diseases, fungal and bacterial pathogenesis, and molecular diagnostics. He investigates rare infections like mucormycosis, listerial peritonitis, and Naegleria fowleri, often in high-risk patients such as those with diabetes, hematologic malignancies, or post-transplant conditions. His work also addresses public health challenges, including undiagnosed AIDS in pediatric monkeypox cases and post-disaster infections. Publications highlight trends in invasive fungal sinusitis, prosthetic joint infections, and rapid diagnostic methods like the Idylla system. His scholarship emphasizes precision medicine, antimicrobial stewardship, and improving diagnostic protocols for challenging cases. He teaches Clinical Pathology (PATH 5009) and contributes to institutional policies on surgical pathology examination standards.